deaths in smokers taking Zyban (bupropion)

March 2002

There's concern over deaths in smokers taking Zyban (bupropion).

So far there are 57 deaths in the United Kingdom.

New Zealand has switched Zyban from a first-line antismoking drug to second-line. Canada and Australia are monitoring it closely.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

early, mild cases of rheumatoid arthritis should get more than just an NSAID
Cardiology More patients will be taking aspirin to prevent heart attacks
Cardiology whether statins cause memory problems
Smoking Cessation deaths in smokers taking Zyban (bupropion)
Gastroenterology Some patients with irritable bowel syndrome are begging the FDA to allow Lotronex (alosetron) back on the market
Gastroenterology treat H. pylori before starting chronic NSAIDs
using cholinesterase inhibitors for patients with VASCULAR dementia
Dermatology Sporanox (itraconazole) to PREVENT recurrent tinea versicolor
Dermatology Elidel, a new cream for eczema
"sudden sleep attacks" in Parkinson's patients while driving
Multiple sclerosis patients are hearing a lot about Prokarin
monitoring patients on antipsychotics for obesity, diabetes, and dyslipidemia
teens abusing Coricidin HBP Cough and Cold tablets
Finally we have a NATIONAL poison hotline, 800-222-1222
Anticoagulants new anticoagulant called Arixtra
Anticoagulants which antibiotics are safe to use in patients on warfarin
Renal & Urology Can patients with recurrent kidney stones take calcium